Основой научно-аналитического исследования явились данные электронных библиотек e-Library.ru, Cochrane-Library и КиберЛенинка, поисковой системы Академии Google и баз медицинских статей PubMed-NCBI, Embase и Medline.
Summarizing the data from the follow-up of patients who underwent COVID-19 indicated that, unlike in case of other epidemic viral diseases, pathological symptoms and complaints associated with respiratory dysfunction after COVID-19 persist for a long time, for several weeks and months after the end of treatment. Recently, an important role in maintaining the homeostasis of the respiratory tract has been assigned to the intestinal microbiota, so the use of probiotics is a promising direction in the framework of complex rehabilitation measures in the post-COVID period. The purpose of the study: to identify probiotics with a proven effect on the correction of respiratory symptoms in order to develop a personalized approach to the selection of an optimal probiotic in the post-COVID period.
Основой научно-аналитического исследования явились данные электронных библиотек e-Library.ru, Cochrane-Library и КиберЛенинка, поисковой системы Академии Google и баз медицинских статей PubMed-NCBI, Embase и Medline.